A Study of BGB-11417 in Participants With Myeloid Malignancies

NCT04771130 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasm

Interventions

DRUG: BGB-11417
DRUG: Azacitidine
DRUG: Posaconazole
DRUG: BGB-11417
DRUG: BGB-11417

Sponsor

BeiGene